22nd Century Group's Gross Margin Progress and Legacy Transition Timelines Clash in Back-to-Back Earnings Calls

Tuesday, Sep 1, 2026 1:13 pm ET2min read
XXII--
Aime RobotAime Summary

- 22nd Century GroupXXII-- reported Q2 2026 revenue of $2.9M, down 29% sequentially, due to intentional shift from low-margin contract manufacturing to higher-margin nicotine-reduced products.

- Gross loss narrowed to $0.3MMMM-- in Q2 2026, reflecting improved margins from Pinnacle/VLN product focus and reduced reliance on legacy CMO contracts.

- The company aims to expand distribution to 5,000 retail outlets by year-end 2026 across 35 states, prioritizing profitable growth through brand development and pricing discipline.

- Management expects margin improvement in H2 2026 from recurring sales, product mix optimization, and completion of legacy contract manufacturing transition by early Q1 2027.

Date of Call: Aug 13, 2026

Financials Results

  • Revenue: $2.9M for Q2 2026, down 29% sequentially from $4.1M in Q1 2026; $7M for H1 2026, down from $10M in H1 2025
  • Gross Margin: Gross loss of $0.3M for Q2 2026, improved from a loss of $0.6M in Q1 2026 and $0.6M in Q2 2025; full-year H1 gross loss $0.9M vs $1.2M in H1 2025
  • Operating Margin: Operating loss of $3.3M for Q2 2026, increased from a loss of $3.0M in Q1 2026

Guidance:

  • Expect a second half inflection in execution on distribution growth and margin improvement.
  • Target expansion to ~5,000 retail outlets by year-end 2026 across 35 states for VLN and Pinnacle VLN products.
  • Expect continued portfolio expansion and higher margin reorder activity to improve gross margin.
  • Anticipate additional large retailer and new trade channel interest converting to productive accounts.
  • Plan to present at the H.C. Wainwright Conference in September and other conferences in Q4.

Business Commentary:

Revenue Decline and Strategic Shift:

  • 22nd Century Group reported net revenue of $2.9 million for Q2 2026, a sequential decline of 29% from Q1 2026, and $7 million for the first half of 2026, down from $10 million in the first half of 2025.
  • The decline was due to the intentional transformation of the business, shifting away from the contract manufacturing business towards higher-margin reduced nicotine products and branded offerings.

Gross Margin Improvement:

  • The company's gross loss for Q2 2026 was $0.3 million, compared to a gross loss of $0.6 million in Q1 2026, and a year-over-year improvement from the $0.6 million loss in Q2 2025.
  • This improvement is attributed to the shift away from low-margin contract manufacturing volumes towards higher-margin Pinnacle and VLN SKUs.

Distribution Expansion:

  • 22nd Century ended the quarter with a retail presence in approximately 2,000 stores across 20 states and aims to expand to 5,000 retail outlets by year-end 2026 across 35 states.
  • The expansion is driven by the company's focus on building a scaled distribution of its higher-margin products and improving product mix.

Focus on Profitable Growth:

  • The company is prioritizing profitable growth over uneconomic volume by investing in brands that can win at retail and aligning its commercial model, pricing strategy, and manufacturing footprint.
  • This strategy is aimed at moving decisively away from legacy business that did not generate acceptable economics.

Sentiment Analysis:

Overall Tone: Positive

  • "The second quarter was an important period for our company. We continued executing a strategy that is reshaping 22nd Century into a stronger, more focused, and ultimately more profitable business." "We do believe the building blocks for gross margin enhancement are materially stronger than they were at the start of the year." "We believe the commercial traction we’re seeing today is laying the groundwork for stronger margins, stronger recurring revenue, and stronger shareholder value over time."

Q&A:

  • Question from (Analyst Name not specified): Concerns about the sequential revenue decline and its impact on the company's growth trajectory.
    Response: Management attributed the decline to the intentional shift away from low-margin contract manufacturing towards higher-margin branded products, which is expected to drive future profitability.

  • Question from (Analyst Name not specified): Regarding the gross margin trajectory and the steps being taken to improve it.
    Response: Management highlighted three forces: expanding higher-margin product distribution, moving from initial load-ins to repeat sales for better absorption, and pricing discipline, with an expectation of benefits in the second half.

  • Question from (Analyst Name not specified): On the timeline for transitioning away from legacy contract manufacturing business.
    Response: Management expects the majority of remaining legacy CMO volume in categories like filtered cigars and export cigarettes to be substantially transitioned away by early Q1 2027.

Contradiction Point 1

Gross Margin Trajectory and Improvement Pace

Conflicting statements on the speed of gross margin recovery.

Implied from Dan Otto's prepared remarks. - Implied from Dan Otto's prepared remarks.

2026Q2: The pace of improvement has not been as fast as planned, the strategic shift is directionally positive. - Dan Otto(CFO)

What factors contributed to the Q2 revenue decline and how will they impact the gross margin trajectory? - N/A (No Q&A session)

2026Q1: [No direct comparable answer as Q1 had no Q&A session. The contradiction is inferred from the absence of reported Q&A, implying a prior presentation of results without addressing the slower-than-planned improvement pace.] - CEO and CFO (Implied from transcript structure)

Contradiction Point 2

Timeline for Transitioning Legacy CMO Business

Specific timeline provided in Q2 not present in Q1 materials.

Implied from Dan Otto's prepared remarks. - Implied from Dan Otto's prepared remarks.

2026Q2: The transition is expected to stage over the next 2-3 quarters, with the majority...expected to be substantially transitioned by early Q1 2027. - Dan Otto(CFO)

What is the current status of the legacy CMO business and the transition timeline? - N/A (No Q&A session)

2026Q1: [No specific timeline provided for the legacy business transition in the prepared remarks or Q&A (which did not exist).] - CEO and CFO (Implied from transcript structure)

Contradiction Point 3

Pace and Impact of Strategic Shift from Low-Margin Contract Manufacturing

The CFO's assessment of the strategic shift's progress and its financial impact appears contradictory between the two quarters.

Implied from context (based on Dan Otto's prepared remarks) - Implied from context (based on Dan Otto's prepared remarks)

2026Q2: The Q2 revenue decline of ~29%... reflect the company's intentional shift... While the pace of improvement has not been as fast as planned, the strategic shift is directionally positive. - Dan Otto(CFO)

What were the trends in Q2 revenue and gross margin? - Implied from context (general update on company progress, strategy, and financial results)

20260326-2025 Q4: Q4 2025 net revenue was ~$3.6M... reflecting a strategic shift to higher-margin branded products from lower-margin contract manufacturing. Full-year 2025 net revenue was ~$17.6M, down from 2024 due to this strategic repositioning. - Dan Otto(CFO)

Contradiction Point 4

Timeline for Transitioning Legacy Business Volume

The expected duration to transition remaining legacy contract manufacturing volume is presented differently, impacting the outlook for future revenue and costs.

What is the current status of the legacy CMO business and the timeline for its transition? - Implied from context (question about the status of the legacy CMO business and transition timeline)

2026Q2: The transition is expected to stage over the next 2-3 quarters, with the majority of remaining legacy volume... expected to be substantially transitioned by early Q1 2027. - Dan Otto(CFO)

What is the current status of the legacy CMO business and the timeline for its transition? - Implied from context (general update on company progress, strategy, and financial results)

20260326-2025 Q4: The company ended the year with ~$7.1M in cash and $0 in long-term debt... It is now in the growth phase... - Dan Otto(CFO) [Implied by context that the transition was completed by the end of 2025, as the company is now in the growth phase with no remaining debt, contrasting the 2-3 quarter transition timeline starting in Q2 2026]

Contradiction Point 5

Capital Allocation Strategy and Warrant Settlement

Contradiction on using cash to settle outstanding warrants.

Can you provide an update on the company's cash position and capital allocation strategy? - Not explicitly stated, but based on Dan Otto's prepared remarks, the question likely pertained to the cash position and capital allocation.

2026Q2: Capital allocation remains disciplined, with spending prioritized on distribution growth, VLN commercial support, Pinnacle portfolio launches, marketing, and advancing the reduced nicotine pipeline. - Dan Otto(CFO)

Not explicitly stated. - Andrew White (Emerging Growth Research)

2025Q3: The company does not intend to use cash to settle outstanding warrants. - Daniel Otto(CFO)

Discover what executives don't want to reveal in conference calls

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



No comments

No comments yet